Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains
<p>Human tuberculosis (TB) is caused by various members of the <em>Mycobacterium tuberculosis</em> (Mtb) complex. Differences in host response to infection have been reported, illustrative of a need to evaluate efficacy of novel vaccine candidates against multiple...
Автори: | Painter, H, Willcocks, S, Zelmer, A, Reljic, R, Tanner, R, Fletcher, H |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Elsevier
2024
|
Схожі ресурси
Схожі ресурси
-
Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
за авторством: Tanner, R, та інші
Опубліковано: (2021) -
Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
за авторством: Painter, H, та інші
Опубліковано: (2020) -
Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
за авторством: Hannah Painter, та інші
Опубліковано: (2020-02-01) -
The cross-species mycobacterial growth inhibition assay (MGIA) project 2010-2014
за авторством: Brennan, M, та інші
Опубліковано: (2017) -
A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
за авторством: Pepponi, I, та інші
Опубліковано: (2017)